# Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock

> **NCT01367743** · PHASE4 · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 58 (actual)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DRUG:** epinephrine perfusion
- **DRUG:** norepinephrine perfusion

## Key facts

- **NCT ID:** NCT01367743
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367743, "Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01367743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*